Interpace Biosciences (IDXG) grants 554K RSUs to CFO
Rhea-AI Filing Summary
INTERPACE BIOSCIENCES, INC. (IDXG) reported equity compensation transactions for CFO & COO Christopher McCarthy on August 20, 2026. He was granted 554,018 RSUs, of which 277,009 vested immediately and converted into common stock, with 277,009 RSUs scheduled to vest on August 20, 2027, subject to continued service. He also received a stock option for 277,009 shares of common stock at an exercise price of $2.02 per share, expiring August 20, 2036, vesting in four equal annual installments beginning August 20, 2027. After these transactions, he directly held 323,800 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 277,009 shares
Net Buy
4 txns
Insider
McCarthy Christopher
Role
CFO & COO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F2, F3 | 554,018 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F2, F3 | 277,009 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) F4 | 277,009 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 277,009 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 277,009 shares (Direct);
Stock Option (right to buy) — 277,009 shares (Direct);
Common Stock — 323,800 shares (Direct)
Footnotes (4)
- F1. Represents the conversion upon vesting of restricted stock units (RSUs) into shares of common stock of Interpace Biosciences, Inc. On August 20, 2026, the Reporting Person was granted 554,018 RSUs, of which 277,009 vested upon grant and 277,009 will vest on August 20, 2027, subject to the Reporting Person's continued service on such vesting date.
- F2. Each RSU represents a contingent right to receive the economic equivalent of one share of common stock of Interpace Biosciences, Inc.
- F3. On August 20, 2026, the Reporting Person was granted 554,018 RSUs, of which 277,009 vested upon grant and 277,009 will vest on August 20, 2027, subject to the Reporting Person's continued service on such vesting date.
- F4. The options will vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
RSUs granted: 554,018 RSUs
RSUs vested immediately: 277,009 RSUs
RSUs vesting later: 277,009 RSUs
+4 more
7 metrics
RSUs granted
554,018 RSUs
Grant to Christopher McCarthy on August 20, 2026
RSUs vested immediately
277,009 RSUs
Portion of RSU grant vesting upon grant on August 20, 2026
RSUs vesting later
277,009 RSUs
Scheduled to vest on August 20, 2027, subject to continued service
Stock options granted
277,009 options
Stock option grant on August 20, 2026
Option exercise price
$2.02 per share
Exercise price of stock options granted to Christopher McCarthy
Option expiration date
August 20, 2036
Expiration of stock options granted on August 20, 2026
Common shares held after transaction
323,800 shares
Direct holdings of common stock after August 20, 2026 transactions
Key Terms
Restricted Stock Units, Stock Option, vesting, exercise or conversion of derivative security
4 terms
Restricted Stock Units financial
"Represents the conversion upon vesting of restricted stock units (RSUs) into shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option financial
"The options will vest in four equal annual installments beginning on August 20, 2027"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"of which 277,009 vested upon grant and 277,009 will vest on August 20, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security"
FAQ
What equity awards did IDXG grant to Christopher McCarthy on August 20, 2026?
Christopher McCarthy received 554,018 RSUs and a stock option for 277,009 shares of INTERPACE BIOSCIENCES, INC. common stock on August 20, 2026, as disclosed in the Form 4.
How many IDXG RSUs vested immediately for Christopher McCarthy and how many are deferred?
Of the 554,018 RSUs granted, 277,009 vested upon grant and 277,009 will vest on August 20, 2027, subject to Christopher McCarthy’s continued service on that vesting date.
What are the key terms of Christopher McCarthy’s new stock option from IDXG?
The stock option covers 277,009 shares of INTERPACE BIOSCIENCES, INC. common stock at an exercise price of $2.02 per share, expiring on August 20, 2036. It vests in four equal annual installments beginning August 20, 2027, subject to continued service.
How did the RSU grant for IDXG convert into common stock for Christopher McCarthy?
Each RSU represents the right to receive the economic equivalent of one share of common stock. On August 20, 2026, 277,009 RSUs vested and converted into 277,009 shares of INTERPACE BIOSCIENCES, INC. common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
